The CDC’s nationwide study reveals varying long COVID prevalence across the USA, from 1.9% in the Virgin Islands to 10.6% in West Virginia, underscoring the need for targeted public health strategies.
Merck details win for Keytruda in bladder cancer after surgery
Merck’s top-selling cancer drug Keytruda cut the risk of bladder cancer coming back or death after surgery by 31%, according to new data shared Friday